Steve D. Wilton

Also affiliated with Perron Institute for Neurological and Translational Science, Avenir Health

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Single Exon Skipping Can Address a Multi-Exon Duplication in the Dystrophin Gene”.

Single Exon Skipping Can Address a Multi-Exon Duplication in the Dystrophin Gene

International Journal of Molecular Sciences(2020)10.3390/ijms21124511

N/A

0DataRank · unranked

4 citations

R. Johnsen, Yoram Nevo, Yakov Fellig, Sue Fletcher, Steve D. Wilton +1 more

Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.06.003

N/A

0DataRank · unranked

53 citations

Michal Irony‐Tur Sinai, Anita Golec, Ofra Barchad-Avitzur, Venkateshwar Mutyam, Li Yao +13 more

Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10kb C-to-T splicing mutation

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.14.431123

N/A

0DataRank · unranked

4 citations

Michal Irony‐Tur Sinai, Anita Golec, Ofra Barchad-Avitzur, Venkateshwar Mutyam, Li Yao +11 more

The recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy

medRxiv(2024)10.1101/2024.03.29.24304673

N/A

0DataRank · unranked

2 citations

Véronique Bolduc, Fady Guirguis, Sandra Donkervoort, Ying Hu, Rotem Orbach +64 more